GBS (GBS) Competitors

InspireMD (NYSE:NSPR) and GBS (NYSE:GBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Which has better valuation and earnings, NSPR or GBS?

GBS has lower revenue, but higher earnings than InspireMD. GBS is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$7.03M	9.83	-$19.92M	-$0.79	-2.85
GBS	N/A	N/A	-$8.31M	-$0.56	-3.18

Does the media refer more to NSPR or GBS?

In the previous week, InspireMD had 1 more articles in the media than GBS. MarketBeat recorded 1 mentions for InspireMD and 0 mentions for GBS. InspireMD's average media sentiment score of 1.73 beat GBS's score of 0.09 indicating that InspireMD is being referred to more favorably in the media.

Company	Overall Sentiment
InspireMD	Very Positive
GBS	Neutral

Which has more risk and volatility, NSPR or GBS?

InspireMD has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, GBS has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.

Is NSPR or GBS more profitable?

GBS has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat GBS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
GBS	N/A	-85.64%	-54.42%

Do institutionals and insiders have more ownership in NSPR or GBS?

44.8% of InspireMD shares are held by institutional investors. Comparatively, 2.8% of GBS shares are held by institutional investors. 34.1% of InspireMD shares are held by company insiders. Comparatively, 0.3% of GBS shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts rate NSPR or GBS?

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 99.56%. Given InspireMD's stronger consensus rating and higher probable upside, research analysts clearly believe InspireMD is more favorable than GBS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
GBS	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

InspireMD beats GBS on 10 of the 15 factors compared between the two stocks.